文献速递贫血与红细胞疾病

成人非输血依赖型地中海贫血的延迟识别与显著发病率

Delayed recognition and significant morbidity in adults with non-transfusion-dependent thalassemia.
PubMed 文献 · Blood Adv · 2026-01-01

多机构研究纳入2013至2023年间转诊至3个美国地中海贫血中心的82例≥18岁非输血依赖型地中海贫血患者,中位首诊年龄36.8岁,45%为α型、55%为β型。71%可评估肝脏MRI显示肝铁>5 mg Fe/g干重,其中仅24.4%转诊时接受祛铁治疗,49%会诊后被建议开始定期输血。

要点

  • 成人首诊非输血依赖型地中海贫血患者并发症发生率高,铁过载普遍且治疗不足。
  • 肝铁>5 mg Fe/g干重者中仅24.4%转诊时接受祛铁治疗。
  • 49%患者会诊后被建议开始定期输血,主要因症状性贫血或无效造血并发症。

核心结论

  • 成人期首次转诊接受综合地中海贫血治疗的非输血依赖型患者发病率高且铁过载治疗不足。
  • 需广泛实施定期输血启动标准以减轻长期并发症并改善生活质量。

研究设计与样本

  • 多机构研究纳入2013至2023年间转诊至3个美国地中海贫血中心的82例≥18岁非输血依赖型地中海贫血患者。
  • 通过人工病历回顾收集临床病史、实验室检查和影像学数据。

主要发现

  • 首诊中位年龄36.8岁(范围18-74),37例(45%)为α地中海贫血,45例(55%)为β地中海贫血。
  • 71%可评估肝脏磁共振图像显示肝铁>5 mg Fe/g干重。
  • 肝铁浓度>5 mg Fe/g的患者中仅24.4%转诊时接受祛铁治疗。
  • 49%患者会诊后被建议开始定期输血,主要因症状性贫血或无效造血并发症。

关键数值与推荐

  • 肝铁>5 mg Fe/g干重定义为铁过载。
  • 定期输血推荐主要针对症状性贫血或无效造血并发症。

临床怎么用

  • 成人非输血依赖型地中海贫血首诊时应系统评估铁过载及并发症。
  • 对肝铁>5 mg Fe/g干重者应评估并启动祛铁治疗。
  • 符合症状性贫血或无效造血并发症者应考虑定期输血。

局限性

  • 回顾性多机构研究,样本量82例。
  • 数据通过人工病历回顾收集,可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Non-transfusion-dependent thalassemia (NTDT) is characterized by variable degrees of anemia, ineffective erythropoiesis, and iron overload, with a heightened risk of age-related complications. However, the clinical profiles of patients who first present to thalassemia care in adulthood, as well as the gaps in management, are poorly described. In a multi-institutional study, we identified 82 patients with NTDT, aged ≥18 years, who were referred to 3 US thalassemia centers between 2013 and 2023. Data were collected by manual chart review and included clinical history, laboratory tests, and imaging. The median age at initial visit was 36.8 years (range, 18-74), and 37 (45%) patients had α-thalassemia, whereas 45 (55%) had β-thalassemia. Complications assessed included symptomatic anemia, previous splenectomy, extramedullary hematopoiesis, iron overload, pulmonary hypertension, cardiac arrhythmia, endocrine complications, and thrombosis. Iron overload was common, with 71% of available liver magnetic resonance images showing hepatic iron of >5 mg Fe/g dry weight. Among patients with liver iron concentration of >5 mg Fe/g, only 24.4% were on chelation at referral. Strikingly, 49% of patients were recommended to start regular transfusions after the consultation, predominantly for symptomatic anemia or complications of ineffective erythropoiesis. Patients with NTDT referred for initial comprehensive thalassemia care in adulthood had high rates of morbidities and undertreated iron overload. The criteria for initiating regular transfusions must be widely implemented to mitigate long-term complications and improve the quality of life of adults with NTDT.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Cheng AN, Peslak S, Sheth S, et al. Delayed recognition and significant morbidity in adults with non-transfusion-dependent thalassemia. Blood Adv. 2026. PMID: 42314035. doi:10.1182/bloodadvances.2026020059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。